April 30, 2020 / 11:16 AM / a month ago

BRIEF-Concert Pharmaceuticals Reports Q1 2020 Financial Results

April 30 (Reuters) - Concert Pharmaceuticals Inc:

* CONCERT PHARMACEUTICALS REPORTS FIRST QUARTER 2020 FINANCIAL RESULTS AND PROVIDES UPDATE ON CLINICAL PROGRAMS

* Q1 LOSS PER SHARE $0.70

* Q1 EARNINGS PER SHARE ESTIMATE $-0.78 — REFINITIV IBES DATA

* CONTINUING TO MOVE FORWARD DEVELOPMENT OF OUR TWO CLINICAL DRUG CANDIDATES Source text for Eikon: Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below